Skip to content Skip to navigation menu

5'-Thiol Modifier C6 S-S CE-Phosphoramidite

5'-Thiol Modifier C6 S-S CE-Phosphoramidite

CAS No.:148254-21-1

Phosphoramidite for the incorporation of a thiol function at the 5' end of an oligonucleotide.

Key features

Show Hide
  • Incorporates a thiol reactive functional group for conjugation.
  • Robust protocol; thiol is liberated by use of tris(2-carboxyethyl)phosphine (TCEP).
  • Can utilise DMT-ON purification prior to reduction of the disulphide bridge.
  • This disulphide product can also be used to modify the 3'-position by using the phosphoramidite as the first adduct in the oligo sequence.
Option 1: Select a Size
Option 2: Select a Bottle Type
TBD
Add to basket to request a quote

Product information

Incorporation of a thiol reactive functional group at specific sites within an oligonucleotide allows for subsequent post-synthesis conjugation of the oligo with a number of different moieties such as fluorescent markers and biotin, depending on the application. Such labels need to be reactive towards the incorporated functional group: for example, thiols will react with iodoacetate and maleimide derivatives to form thioether linkages.
In general, thiol modification at the 5'-end of the oligonucleotide is achieved with C6 5'-thiol-modifier phosphoramidite (LK2125/BNS-5019) or, more commonly, the thiol-modifier C6 S-S phosphoramidite (LK2126/BNS-5042/BA0037). As with the MMT protected amino-modifiers, the trityl group on LK2125/BNS-5019 is usually retained after cleavage of the oligonucleotide to assist purification. However, because the S-trityl group is not acid labile, it must be removed by treatment with silver nitrate. Although, this procedure is commonly used it must be very carefully carried out. Use of LK2126/BNS-5042/BA0037 offers an alternative and more robust protocol, whereby the thiol is liberated by use of tris(2-carboxyethyl)phosphine (TCEP). This disulphide product can also be used to modify the 3'-position by using the phosphoramidite as the first adduct in the oligo sequence. Incorporation of LK2126/BNS-5042/BA0037 at the 5'-end allows the possibility of DMT-ON purification prior to reduction of the disulphide bridge.

Access support

Need some support with placing an order, setting up an account, or finding the right protocol?

Contact us